Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Alpharetta, Georgia
- Most recent report
- 8-K, filed Oct 19, 2026
- Incorporated
- Delaware
- Filings on record
- 324 filings
- On EDGAR
- CIK 1818844
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 24
News 8 of 74
- 8-K Significant contract Oct 19, 2026
- 8-K Quarterly results Aug 13, 2026
- 8-K Shareholder vote results Jun 17, 2026
- 8-K Quarterly results May 14, 2026
- 8-K Current report on a material event Mar 26, 2026
- 8-K Quarterly results Mar 18, 2026
- 8-K Shareholder vote results Mar 12, 2026
- 8-K Current report on a material event Jan 20, 2026
Prospectuses and Registrations 8 of 29
- S-3 Shelf registration statement Jan 15, 2026
- 424B5 Prospectus supplement for an offering Jan 13, 2026
- S-8 Registration statement for an employee plan Jan 8, 2026
- 424B5 Prospectus supplement for an offering Nov 28, 2025
- S-3/A Shelf registration statement, amended Oct 16, 2025
- S-3 Shelf registration statement Oct 1, 2025
- S-8 Registration statement for an employee plan Jun 26, 2025
- S-3 Shelf registration statement May 23, 2025
Proxies 8 of 21
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- PRE 14A Preliminary proxy statement Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Feb 13, 2026
- PRE 14A Preliminary proxy statement Jan 23, 2026
- DEF 14A Proxy statement for a shareholder vote Oct 20, 2025
- DEFA14A Extra proxy material Oct 9, 2025
- PRE 14A Preliminary proxy statement Oct 8, 2025
- DEFA14A Extra proxy material Sep 29, 2025
Ownership 8 of 144
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- 4 Insider reported a trade Jun 17, 2026
- SCHEDULE 13G Large holder reported a passive stake May 15, 2026
- 4 Insider reported a trade Mar 6, 2026
- 4 Insider reported a trade Mar 6, 2026
Other 8 of 32
- ARS Annual report sent to shareholders Apr 27, 2026
- EFFECT Notice that a registration became effective Jan 29, 2026
- CORRESP Reply to SEC staff Jan 27, 2026
- UPLOAD Comment letter from SEC staff Jan 27, 2026
- EFFECT Notice that a registration became effective Jun 2, 2025
- CORRESP Reply to SEC staff May 29, 2025
- UPLOAD Comment letter from SEC staff May 28, 2025
- ARS Annual report sent to shareholders Apr 30, 2025
Everything here comes from Dogwood Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.